We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There was no correlation observed between in-hospital ...

Please provide your email address to receive an email when new articles are posted on . In hospitalized patients with COVID-19, famotidine was correlated with a lower mortality risk, lower risk for ...

For a small group of nonhospitalized patients with coronavirus disease 2019 (COVID-19), self-administration of high-dose oral famotidine was found to be associated with improvements in disease-related ...

NEW YORK -- Over the past few weeks researchers have been studying a new potential treatment for COVID-19 and it might not be what many people expect. Researchers at Northwell Health have been ...

Pepcid products are commonly used to prevent and treat heartburn caused by acid indigestion and upset stomach. The main active ingredient in Pepcid is famotidine, which belongs to a class of medicines ...

A patient-reported symptom tracking method used for patients with cancer has now been adapted for patients with COVID-19. The first clinical case series showed that famotidine may help COVID-19 ...

COLD SPRING HARBOR, NY — Famotidine, the heartburn drug known as Pepcid, has been shown to reduce coronavirus symptoms and body inflammation, according to a study by Feinstein Institutes for Medical ...

Use of famotidine in a small group of 83 patients was associated with a lower risk of in-hospital mortality and a combined outcome of death and intubation, reported Jeffrey Mather, MS, of Hartford ...

Ten people who were home sick with Covid-19 may have found relief with a common over-the-counter heartburn remedy, according to a study published Thursday. A coauthor of the study emphasized that it’s ...

Ibuprofen, famotidine 800mg/26.6mg; tabs. Ibuprofen has analgesic, antiinflammatory, and antipyretic properties. The mechanism of action of the ibuprofen, like that of other NSAIDs, is not completely ...

Aristos is a Newsweek science and health reporter with the London, U.K., bureau. He is particularly focused on archaeology and paleontology, although he has covered a wide variety of topics ranging ...